Inhibition of influenza virus replication by plant-derived isoquercetin

Antiviral Research

Volumn 88, Issue 2, 2010, Pages 227-235

  Kim, Yunjeong ^a   Narayanan, Sanjeev ^a   Chang, Kyeong Ok ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Antiviral; Influenza virus; Isoquercetin; Polyphenols; Resistance

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; FISETIN; GAMMA INTERFERON; HYPERICUM PERFORATUM EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOQUERCETIN; OSELTAMIVIR; POLYPHENOL; QUERCETIN; RANTES; RESVERATROL; RUTOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG POTENTIATION; FEMALE; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS INHIBITION; VIRUS REPLICATION;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, VIRAL; DRUG SYNERGISM; EQUISETUM; FEMALE; HUMANS; HYPERICUM; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PLANT EXTRACTS; QUERCETIN; VERO CELLS; VIRUS REPLICATION;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 77958153284     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.08.016     Document Type: Article

References (53)

1. Akaike T., Maeda H. Nitric oxide and virus infection. Immunology 2000, 101(3):300-308.
2. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., Dietzschold B., Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(6):2448-2453.
3. Allen T.C. Laboratory methods in histotechnology. Hematoxylin and Eosin 1992, American Registry of Pathology, Washington, DC. E.B. Prophet, B. Mills, J.B. Arrington, L.H. Sobin (Eds.).
4. Bright R.A., Shay D.K., Shu B., Cox N.J., Klimov A.I. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006, 295(8):891-894.
5. Chanh P.H., Ifansyah N., Chahine R., Mounayar-Chalfoun A., Gleye J., Moulis C. Comparative effects of total flavonoids extracted from Ribes nigrum leaves, rutin and isoquercitrin on biosynthesis and release of prostaglandins in the ex vivo rabbit heart. Prostaglandins Leukot. Med. 1986, 22(3):295-300.
6. Chen L., Li J., Luo C., Liu H., Xu W., Chen G., Liew O.W., Zhu W., Puah C.M., Shen X., Jiang H. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg. Med. Chem. 2006, 14(24):8295-8306.
7. Chiang L.C., Chiang W., Liu M.C., Lin C.C. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J. Antimicrob. Chemother. 2003, 52(2):194-198.
8. Choi H.J., Kim J.H., Lee C.H., Ahn Y.J., Song J.H., Baek S.H., Kwon D.H. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res. 2009, 81(1):77-81.
9. Choi H.J., Song J.H., Park K.S., Kwon D.H. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur. J. Pharm. Sci. 2009, 37(3-4):329-333.
10. Davis J.M., Murphy E.A., McClellan J.L., Carmichael M.D., Gangemi J.D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295(2):R505-R509.
11. Debiaggi M., Tateo F., Pagani L., Luini M., Romero E. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica 1990, 13(3):207-213.
12. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., St George K., Epperson S., Brammer L., Klimov A.I., Bresee J.S., Fry A.M. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301(10):1034-1041.
13. Docherty J.J., Fu M.M., Stiffler B.S., Limperos R.J., Pokabla C.M., DeLucia A.L. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 1999, 43(3):145-155.
14. Docherty J.J., Sweet T.J., Bailey E., Faith S.A., Booth T. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res. 2006, 72(3):171-177.
15. Fraga C.G., Martino V.S., Ferraro G.E., Coussio J.D., Boveris A. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol. 1987, 36(5):717-720.
16. Furuta T., Hirooka Y., Abe A., Sugata Y., Ueda M., Murakami K., Suzuki T., Tanaka K., Kan T. Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity. Bioorg. Med. Chem. Lett. 2007, 17(11):3095-3098.
17. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
18. Govorkova E.A., Fang H.B., Tan M., Webster R.G. Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob. Agents Chemother. 2004, 48(12):4855-4863.
19. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994, 344(8924):721-724.
20. Hayden F.G., Sperber S.J., Belshe R.B., Clover R.D., Hay A.J., Pyke S. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob. Agents Chemother. 1991, 35(9):1741-1747.
21. Heredia A., Davis C., Redfield R. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J. Acquir. Immune Defic. Syndr. 2000, 25(3):246-255.
22. Ilyushina N.A., Hoffmann E., Salomon R., Webster R.G., Govorkova E.A. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir. Ther. 2007, 12(3):363-370.
23. Kaul T.N., Middleton E., Ogra P.L. Antiviral effect of flavonoids on human viruses. J. Med. Virol. 1985, 15(1):71-79.
24. Kazlauskas S., Bagdonaite E. Quantitative analysis of active substances in St. John's wort (Hypericum perforatum L.) by the high performance liquid chromatography method. Medicina (Kaunas) 2004, 40(10):975-981.
25. Lakhanpal P., Rai D.K. Quercetin: a versatile flavonoid. Int. J. Med. Update 2007, 2(2,):22-37.
26. Lee S., Park H.S., Notsu Y., Ban H.S., Kim Y.P., Ishihara K., Hirasawa N., Jung S.H., Lee Y.S., Lim S.S., Park E.H., Shin K.H., Seyama T., Hong J., Ohuchi K. Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide-induced nitrite production in rat peritoneal macrophages. Phytother. Res. 2008, 22(11):1552-1556.
27. Li W., Fitzloff J.F. High performance liquid chromatographic analysis of St. John's wort with photodiode array detection. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 765(1):99-105.
28. Marjuki H., Wernery U., Yen H.L., Franks J., Seiler P., Walker D., Krauss S., Webster R.G. Isolation of highly pathogenic avian influenza H5N1 virus from Saker falcons (Falco cherrug) in the Middle East. Adv. Virol. 2009, 2009:1.
29. Matsukura S., Kokubu F., Kubo H., Tomita T., Tokunaga H., Kadokura M., Yamamoto T., Kuroiwa Y., Ohno T., Suzaki H., Adachi M. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am. J. Respir. Cell Mol. Biol. 1998, 18(2):255-264.
30. Mimica-Dukic N., Simin N., Cvejic J., Jovin E., Orcic D., Bozin B. Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants. Molecules 2008, 13(7):1455-1464.
31. Mitrocotsa D., Mitaku S., Axarlis S., Harvala C., Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med. 2000, 66(4):377-379.
32. MMWR Update: swine influenza A (H1N1) infections - California and Texas, April 2009. Morb. Mortal Wkly. Rep. 2009, 58:1-3.
33. Mori S., Miyake S., Kobe T., Nakaya T., Fuller S.D., Kato N., Kaihatsu K. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length. Bioorg. Med. Chem. Lett. 2008, 18(14):4249-4252.
34. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993, 21(4):289-299.
35. Palamara A.T., Nencioni L., Aquilano K., De Chiara G., Hernandez L., Cozzolino F., Ciriolo M.R., Garaci E. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 2005, 191(10):1719-1729.
36. Palese P., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields Virology 2007, vol. 2:1647-1690. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia.
37. Poland G.A., Jacobson R.M., Ovsyannikova I.G. Influenza virus resistance to antiviral agents: a plea for rational use. Clin. Infect. Dis. 2009, 48(9):1254-1256.
38. Prichard M.N., Shipman C. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990, 14(4-5):181-205.
39. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hygiene 1938, 27:493-497.
40. Rogerio A.P., Kanashiro A., Fontanari C., da Silva E.V., Lucisano-Valim Y.M., Soares E.G., Faccioli L.H. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm. Res. 2007, 56(10):402-408.
41. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., de Jong J.C., Kielso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A., Smith D.J. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008, 26 Suppl 4:D31-D34.
42. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130(8S Suppl):2073S-2085S.
43. Schweiger B., Zadow I., Heckler R., Timm H., Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J. Clin. Microbiol. 2000, 38(4):1552-1558.
44. Shoskes Effect of bioflavonoid quercetin and curcumin on ischaemic renal injury: a new class of renoprotective agent. Transplantation 1998, 66:147-152.
45. Shutenko Z., Pinard H.Y.E. Influence of antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem. Pharmacol. 1990, 57(199-208):199.
46. Smee D.F., Hurst B.L., Wong M.H., Bailey K.W., Morrey J.D. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob. Agents Chemother. 2009, 53(5):2120-2128.
47. Song J.M., Lee K.H., Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005, 68(2):66-74.
48. Tatsis E.C., Boeren S., Exarchou V., Troganis A.N., Vervoort J., Gerothanassis I.P. Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS. Phytochemistry 2007, 68(3):383-393.
49. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
50. Vincent A.L., Swenson S.L., Lager K.M., Gauger P.C., Loiacono C., Zhang Y. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Vet. Microbiol. 2009, 137(1-2):51-59.
51. Weber J.M., Ruzindana-Umunyana A., Imbeault L., Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res. 2003, 58(2):167-173.
52. WHO Pandemic (H1N1) 2009 - Update 57 2009.
53. Xiao X., Yang Z.Q., Shi L.Q., Liu J., Chen W. Antiviral effect of epigallocatechin gallate (EGCG) on influenza A virus. Zhongguo Zhong Yao Za Zhi 2008, 33(22):2678-2682.